Susan E. Atkins insider trades
Open-market stock purchases and sales by Susan E. Atkins, Director at BioXcel Therapeutics, Inc, from SEC Form 4 filings since Aug 12, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 12, 2026 | BTAI BioXcel Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- BTAI BioXcel Therapeutics, Inc: other filings, last Aug 12, 2026